For instance, Ginsenoside F4, which acts as a PTP1B inhibitor, has been demonstrated to significantly improve the hyperglycemic status of db/db mice and to mitigate skeletal muscle insulin resistance [142]. The gene discussed is PTPN1; the disease is Insulin resistance.